MedTrace Logo

RESynchronizaTiOn theRapy and bEta-blocker Titration

NCT02173028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 254

Last updated 2017-02-24

No results posted yet for this study

Summary

Patients will be treated according to the clinical practice of the participating centers and to the international guidelines for the treatment of heart failure.The present analysis provides a collection of data about the changes to drug therapy after the "Cardiac Resynchronization Therapy" (CRT) procedure , and any signs and symptoms of intolerance to prescribed medications.

Conditions

  • Beta Blocker Intolerance
  • Congestive Heart Failure

Sponsors & Collaborators

  • Giuseppe Ricciardi

    lead OTHER

Principal Investigators

  • Edoardo Gronda · MultiMedica

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02173028 on ClinicalTrials.gov